CATNAP: A tool to compile, analyze and tally neutralizing antibody panels

Nucleic Acids Research

Volumn 43, Issue W1, 2015, Pages W213-W219

  Yoon, Hyejin ^a   Macke, Jennifer ^a   West, Anthony P ^b   Foley, Brian ^a   Bjorkman, Pamela J ^b   Korber, Bette ^a   Yusim, Karina ^a  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

^b CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; COMPILE ANALYZE AND TALLY NAB PANELS; COMPUTER SYSTEM; DATA ANALYSIS; DATA BASE; EPIDEMIOLOGICAL DATA; FISHER EXACT TEST; GLYCOSYLATION; INFORMATION PROCESSING; INFORMATION RETRIEVAL; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; SOFTWARE; CHEMISTRY; COMPUTER PROGRAM; IC50; INTERNET; SEQUENCE ANALYSIS;

ANTIBODIES, NEUTRALIZING; HIV ANTIBODIES; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; INHIBITORY CONCENTRATION 50; INTERNET; SEQUENCE ANALYSIS, PROTEIN; SOFTWARE; VIRAL ENVELOPE PROTEINS;

EID: 84979866871     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv404     Document Type: Article

References (31)

1. Gaschen, B., Taylor, J., Yusim, K., Foley, B., Gao, F., Lang, D., Novitsky, V., Haynes, B., Hahn, B.H., Bhattacharya, T. et al. (2002) Diversity considerations in HIV-1 vaccine selection. Science, 296, 2354-2360.
2. Burton, D.R., Poignard, P., Stanfield, R.L. and Wilson, I.A. (2012) Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science, 337, 183-186.
3. Scheid, J.F., Mouquet, H., Ueberheide, B., Diskin, R., Klein, F., Oliveira, T.Y., Pietzsch, J., Fenyo, D., Abadir, A., Velinzon, K. et al. (2011) Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science, 333, 1633-1637.
4. Wu, X., Zhou, T., Zhu, J., Zhang, B., Georgiev, I., Wang, C., Chen, X., Longo, N.S., Louder, M., McKee, K. et al. (2011) Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science, 333, 1593-1602.
5. de Camp, A., Hraber, P., Bailer, R.T., Seaman, M.S., Ochsenbauer, C., Kappes, J., Gottardo, R., Edlefsen, P., Self, S., Tang, H. et al. (2014) Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol., 88, 2489-2507.
6. Seaman, M.S., Janes, H., Hawkins, N., Grandpre, L.E., Devoy, C., Giri, A., Coffey, R.T., Harris, L., Wood, B., Daniels, M.G. et al. (2010) Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies. J. Virol., 84, 1439-1452.
7. Montefiori, D.C. (2005) Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays. Curr. Protoc. Immunol., Chapter 12, Unit 12.11.
8. West, A.P. Jr, Scharf, L., Horwitz, J., Klein, F., Nussenzweig, M.C. and Bjorkman, P.J. (2013) Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues. Proc. Natl. Acad. Sci. U.S.A., 110, 10598-10603.
9. Eroshkin, A.M., Le Blanc, A., Weekes, D., Post, K., Li, Z., Rajput, A., Butera, S.T., Burton, D.R. and Godzik, A. (2014) bNAber: database of broadly neutralizing HIV antibodies. Nucleic Acids Res., 42, D1133-D1139.
10. Chuang, G.Y., Acharya, P., Schmidt, S.D., Yang, Y., Louder, M.K., Zhou, T., Kwon, Y.D., Pancera, M., Bailer, R.T., Doria-Rose, N.A. et al. (2013) Residue-level prediction of HIV-1 antibody epitopes based on neutralization of diverse viral strains. J. Virol., 87, 10047-10058.
11. Chuang, G.Y., Liou, D., Kwong, P.D. and Georgiev, I.S. (2014) NEP: web server for epitope prediction based on antibody neutralization of viral strains with diverse sequences. Nucleic Acids Res., 42, W64-W71.
12. Gnanakaran, S., Daniels, M.G., Bhattacharya, T., Lapedes, A.S., Sethi, A., Li, M., Tang, H., Greene, K., Gao, H., Haynes, B.F. et al. (2010) Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies. PLoS Comput. Biol., 6, e1000955.
13. Kepler, T.B. (2013) Reconstructing a B-cell clonal lineage. I. Statistical inference of unobserved ancestors. F1000Res, 2, 103.
14. Ye, J., Ma, N., Madden, T.L. and Ostell, J.M. (2013) IgBLAST: an immunoglobulin variable domain sequence analysis tool. Nucleic Acids Res., 41, W34-W40.
15. Giudicelli, V., Brochet, X. and Lefranc, M.P. (2011) IMGT/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences. Cold Spring Harb. Protoc., 695-715.
16. Brochet, X., Lefranc, M.P. and Giudicelli, V. (2008) IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res., 36, W503-W508.
17. Gaeta, B.A., Malming, H.R., Jackson, K.J., Bain, M.E., Wilson, P. and Collins, A.M. (2007) iHMMune-align: hidden Markov model-based alignment and identification of germline genes in rearranged immunoglobulin gene sequences. Bioinformatics, 23, 1580-1587.
18. Souto-Carneiro, M.M., Longo, N.S., Russ, D.E., Sun, H.W. and Lipsky, P.E. (2004) Characterization of the human Ig heavy chain antigen binding complementarity determining region 3 using a newly developed software algorithm, JOINSOLVER. J. Immunol., 172, 6790-6802.
19. Liao, H.X., Lynch, R., Zhou, T., Gao, F., Alam, S.M., Boyd, S.D., Fire, A.Z., Roskin, K.M., Schramm, C.A., Zhang, Z. et al. (2013) Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature, 496, 469-476.
20. Diskin, R., Scheid, J.F., Marcovecchio, P.M., West, A.P. Jr, Klein, F., Gao, H., Gnanapragasam, P.N., Abadir, A., Seaman, M.S., Nussenzweig, M.C. et al. (2011) Increasing the potency and breadth of an HIV antibody by using structure-based rational design. Science, 334, 1289-1293.
21. Pejchal, R., Doores, K.J., Walker, L.M., Khayat, R., Huang, P.S., Wang, S.K., Stanfield, R.L., Julien, J.P., Ramos, A., Crispin, M. et al. (2011) A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science, 334, 1097-1103.
22. Falkowska, E., Ramos, A., Feng, Y., Zhou, T., Moquin, S., Walker, L.M., Wu, X., Seaman, M.S., Wrin, T., Kwong, P.D. et al. (2012) PGV04, an HIV-1 gp120 CD4 binding site antibody, is broad and potent in neutralization but does not induce conformational changes characteristic of CD4. J. Virol., 86, 4394-4403.
23. Blattner, C., Lee, J.H., Sliepen, K., Derking, R., Falkowska, E., de la Pena, A.T., Cupo, A., Julien, J.P., van Gils, M., Lee, P.S. et al. (2014) Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers. Immunity, 40, 669-680.
24. Scharf, L., Scheid, J.F., Lee, J.H., West, A.P. Jr, Chen, C., Gao, H., Gnanapragasam, P.N., Mares, R., Seaman, M.S., Ward, A.B. et al. (2014) Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spike. Cell Rep., 7, 785-795.
25. McLellan, J.S., Pancera, M., Carrico, C., Gorman, J., Julien, J.P., Khayat, R., Louder, R., Pejchal, R., Sastry, M., Dai, K. et al. (2011) Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature, 480, 336-343.
26. Zhou, T., Georgiev, I., Wu, X., Yang, Z.Y., Dai, K., Finzi, A., Kwon, Y.D., Scheid, J.F., Shi, W., Xu, L. et al. (2010) Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science, 329, 811-817.
27. Zhou, T., Xu, L., Dey, B., Hessell, A.J., Van Ryk, D., Xiang, S.H., Yang, X., Zhang, M.Y., Zwick, M.B., Arthos, J. et al. (2007) Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature, 445, 732-737.
28. Kwong, P.D., Wyatt, R., Robinson, J., Sweet, R.W., Sodroski, J. and Hendrickson, W.A. (1998) Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature, 393, 648-659.
29. O'Rourke, S.M., Schweighardt, B., Phung, P., Mesa, K.A., Vollrath, A.L., Tatsuno, G.P., To, B., Sinangil, F., Limoli, K., Wrin, T. et al. (2012) Sequences in glycoprotein gp41, the CD4 binding site, and the V2 domain regulate sensitivity and resistance of HIV-1 to broadly neutralizing antibodies. J. Virol., 86, 12105-12114.
30. Postler, T.S. and Desrosiers, R.C. (2013) The tale of the long tail: the cytoplasmic domain of HIV-1 gp41. J. Virol., 87, 2-15.
31. Doria-Rose, N.A., Georgiev, I., O'Dell, S., Chuang, G.Y., Staupe, R.P., McLellan, J.S., Gorman, J., Pancera, M., Bonsignori, M., Haynes, B.F. et al. (2012) A short segment of the HIV-1 gp120 V1/V2 region is a major determinant of resistance to V1/V2 neutralizing antibodies. J. Virol., 86, 8319-8323.